NUTX Financials

Income Statement
MetricQ2 2026Q2 2026Q1 2026Q1 2026Q4 2025
Revenue
210.8M
+0.0%
210.8M
-2.6%
216.5M
+0.0%
216.5M
+42.7%
151.7M
Cost of Revenue
0
0
0
0
0
Gross Profit
210.8M
+0.0%
210.8M
-2.6%
216.5M
+0.0%
216.5M
+42.7%
151.7M
Operating Expenses
89.0M
+0.0%
89.0M
-34.2%
135.2M
+0.0%
135.2M
+12.0%
120.8M
R&D
0
0
0
0
0
SG&A
62.3M
+0.0%
62.3M
+20.1%
51.9M
+0.0%
51.9M
+196.7%
-53663000
Operating Income
121.7M
+0.0%
121.7M
+49.8%
81.3M
+0.0%
81.3M
+162.8%
30.9M
EBITDA
127.0M
+0.0%
127.0M
+46.4%
86.8M
+0.0%
86.8M
+140.3%
36.1M
Net Income
96.3M
+0.0%
96.3M
+53.5%
62.8M
+0.0%
62.8M
+277.9%
16.6M
EPS (Basic)
$9.58
+0.0%
$9.58
+43.0%
$6.70
+0.0%
$6.70
+301.2%
$1.67
EPS (Diluted)
$9.38
+0.0%
$9.38
+43.9%
$6.52
+0.0%
$6.52
+307.5%
$1.60
Shares (Diluted)
7.0M
+0.0%
7.0M
-2.2%
7.2M
+0.0%
7.2M
-3.0%
7.4M
Nutex Health (NUTX) โ€” Financials